Co-variation between blood stream infections with Candida species versus Pseudomonas aeruginosa, Staphylococcus aureus, and other isolates among 60 ICU patient cohorts.
{"title":"Co-variation between blood stream infections with Candida species versus Pseudomonas aeruginosa, Staphylococcus aureus, and other isolates among 60 ICU patient cohorts.","authors":"James C Hurley","doi":"10.1093/mmy/myag023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcal species, Coagulase-negative Staphylococci, Acinetobacter species, and Candida species are common blood stream infection (BSI) isolates among intensive care unit (ICU) cohorts. That Candida species might interact with bacteria at mucosal surfaces to facilitate invasive infections prompts the question as to the degree of co-variance between Candida species versus bacteria among BSI isolates.</p><p><strong>Objectives: </strong>To estimate the co-variance between Candida species versus each of these five bacteria as BSI isolates among ICU patient cohorts.</p><p><strong>Methods: </strong>The literature was searched opportunistically for studies reporting ICU patient cohorts listing Candida species among BSI isolates. The associations of the BSI incidence proportion per 100 patients were converted to logits and modelled using ellipse plots.</p><p><strong>Results: </strong>The median overall BSI incidence proportion was 7.8% (interquartile range; 4.8%-11.6%). Among 60 cohorts (50 publications), correlation with the incidence proportion of Candidemia was apparent for Acinetobacter species (correlation coefficient = 0.69), Staphylococcus aureus (0.47), and Pseudomonas aeruginosa (0.4) but less so for Coagulase-negative Staphylococci (0.37) and Enterococcal species (0.32).</p><p><strong>Conclusions: </strong>There are various degrees of co-variance between the BSI incidence proportion amongst the five types of bacteria and Candida species among ICU cohorts.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13037462/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myag023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcal species, Coagulase-negative Staphylococci, Acinetobacter species, and Candida species are common blood stream infection (BSI) isolates among intensive care unit (ICU) cohorts. That Candida species might interact with bacteria at mucosal surfaces to facilitate invasive infections prompts the question as to the degree of co-variance between Candida species versus bacteria among BSI isolates.
Objectives: To estimate the co-variance between Candida species versus each of these five bacteria as BSI isolates among ICU patient cohorts.
Methods: The literature was searched opportunistically for studies reporting ICU patient cohorts listing Candida species among BSI isolates. The associations of the BSI incidence proportion per 100 patients were converted to logits and modelled using ellipse plots.
Results: The median overall BSI incidence proportion was 7.8% (interquartile range; 4.8%-11.6%). Among 60 cohorts (50 publications), correlation with the incidence proportion of Candidemia was apparent for Acinetobacter species (correlation coefficient = 0.69), Staphylococcus aureus (0.47), and Pseudomonas aeruginosa (0.4) but less so for Coagulase-negative Staphylococci (0.37) and Enterococcal species (0.32).
Conclusions: There are various degrees of co-variance between the BSI incidence proportion amongst the five types of bacteria and Candida species among ICU cohorts.
期刊介绍:
Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.